CSPIA
LLY icon

Cary Street Partners Investment Advisory’s Eli Lilly LLY Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Buy
2,853
+53
+2% +$54.2K 0.69% 35
2026
Q1 		$2.58M Buy
2,800
+110
+4% +$112K 0.66% 36
2025
Q4 		$2.89M Buy
2,690
+380
+16% +$363K 0.78% 26
2025
Q3 		$1.76M Buy
2,310
+30
+1% +$22.3K 0.74% 25
2025
Q2 		$1.78M Buy
2,280
+36
+2% +$28K 0.86% 23
2025
Q1 		$1.85M Buy
2,244
+200
+10% +$166K 1.07% 16
2024
Q4 		$1.58M Sell
2,044
-23,782
-92% -$19.7M 1.04% 19
2024
Q3 		$22.9M Sell
25,826
-15
-0.1% -$13.5K 0.84% 20
2024
Q2 		$23.4M Sell
25,841
-400
-2% -$320K 0.95% 16
2024
Q1 		$20.4M Sell
26,241
-519
-2% -$369K 0.86% 21
2023
Q4 		$15.6M Buy
26,760
+731
+3% +$427K 0.74% 30
2023
Q3 		$14M Buy
26,029
+315
+1% +$162K 0.75% 26
2023
Q2 		$12.1M Sell
25,714
-1,550
-6% -$650K 0.78% 27
2023
Q1 		$9.36M Sell
27,264
-582
-2% -$196K 0.67% 39
2022
Q4 		$10.2M Sell
27,846
-800
-3% -$284K 0.75% 40
2022
Q3 		$9.26M Buy
28,646
+1,872
+7% +$593K 0.76% 38
2022
Q2 		$8.68M Buy
26,774
+17,676
+194% +$5.31M 0.74% 36
2022
Q1 		$2.6M Buy
9,098
+483
+6% +$124K 0.72% 37
2021
Q4 		$2.38M Buy
8,615
+340
+4% +$86.2K 0.66% 43
2021
Q3 		$1.91M Sell
8,275
-107
-1% -$26.4K 0.63% 50
2021
Q2 		$1.92M Buy
8,382
+2,020
+32% +$406K 0.62% 48
2021
Q1 		$1.19M Sell
6,362
-5,279
-45% -$1.03M 0.49% 57
2020
Q4 		$1.97M Buy
11,641
+5,020
+76% +$750K 0.38% 64
2020
Q3 		$980K Buy
+6,621
New +$1.02M 0.21% 128

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cary Street Partners Investment Advisory's LLY Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its Eli Lilly (LLY) stake by 1.9% in Q2 2026, buying an estimated $54.2K and bringing the position to 2,853 shares worth $3.42M. The position accounts for 0.69% of the portfolio, ranked #35.

Cary Street Partners Investment Advisory first reported a position in LLY in Q3 2020 and has held it in 24 quarters since. The position peaked at $23.4M in Q2 2024. 3,468 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cary Street Partners Investment Advisory held 2,853 shares of Eli Lilly worth $3.42M as of Q2 2026.
  • Cary Street Partners Investment Advisory bought 53 Eli Lilly shares in Q2 2026, an estimated $54.2K.
  • Eli Lilly made up 0.69% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #35 holding.
  • Cary Street Partners Investment Advisory first reported a position in Eli Lilly in Q3 2020 and has held it in 24 quarters since.
  • Cary Street Partners Investment Advisory's Eli Lilly position peaked at $23.4M in Q2 2024.
  • 3,468 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.